Home  »  Industry   »  Forget What the Analysts Say and Check out Trade D...

Forget What the Analysts Say and Check out Trade Data for Tenax Therapeutics Inc. (TENX)

For the readers interested in the stock health of Tenax Therapeutics Inc. (TENX). It is currently valued at $2.84. When the transactions were called off in the previous session, Stock hit the highs of $2.95, after setting-off with the price of $2.39. Company’s stock value dipped to $2.20 during the trading on the day. When the trading was stopped its value was $2.41.

Tenax Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.95 on 01/19/23, with the lowest value was $1.91 for the same time period, recorded on 01/04/23.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Tenax Therapeutics Inc. (TENX) full year performance was -80.01%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Tenax Therapeutics Inc. shares are logging -83.29% during the 52-week period from high price, and 77.49% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.60 and $17.00.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1934711 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Tenax Therapeutics Inc. (TENX) recorded performance in the market was 27.47%, having the revenues showcasing -23.12% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 6.25M, as it employees total of 8 workers.

Market experts do have their say about Tenax Therapeutics Inc. (TENX)

During the last month, 0 analysts gave the Tenax Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.05, with a change in the price was noted -2.28. In a similar fashion, Tenax Therapeutics Inc. posted a movement of -44.55% for the period of last 100 days, recording 226,795 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TENX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical breakdown of Tenax Therapeutics Inc. (TENX)

Raw Stochastic average of Tenax Therapeutics Inc. in the period of last 50 days is set at 55.11%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 89.45%. In the last 20 days, the company’s Stochastic %K was 71.50% and its Stochastic %D was recorded 61.41%.

Bearing in mind the latest performance of Tenax Therapeutics Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 27.47%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -46.92%, alongside a downfall of -80.01% for the period of the last 12 months. The shares increased approximately by 21.36% in the 7-day charts and went up by 10.42% in the period of the last 30 days. Common stock shares were lifted by -23.12% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts